Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,919,202
+$2,720,971 QoQ
Shares Held
21,869
+48.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#637
of 3,140 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. AMGN ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
This page
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,919,202 | 21,869 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,198,231 | 14,774 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $988,476 | 3,020 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,187,449 | 11,295 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,075,926 | 7,435 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $368,805 | 1,415 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,086,492 | 3,372 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,726,438 | 8,726 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,667,965 | 16,418 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $41,613,993 | 144,483 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,451,371 | 27,725 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $36,905,940 | 166,228 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $39,742,007 | 164,393 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,106,243 | 11,827 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,308,997 | 10,244 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,329,433 | 54,786 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,152,106 | 54,388 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,821,773 | 25,878 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,047,101 | 37,842 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,092,881 | 29,099 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $261,250 | 1,050 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,885,344 | 8,200 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||